NYSE:HUM - Humana Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$293.69 +1.80 (+0.62 %)
(As of 05/25/2018 08:35 AM ET)
Previous Close$291.89
Today's Range$291.37 - $295.0850
52-Week Range$223.40 - $299.85
Volume527,552 shs
Average Volume744,658 shs
Market Capitalization$40.19 billion
P/E Ratio25.08
Dividend Yield0.69%
Beta0.95

About Humana (NYSE:HUM)

Humana logoHumana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group and Specialty segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment provides pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. The Individual Commercial segment offers individual commercial fully-insured medical health insurance benefits under the HumanaOne brand. The company also provides closed-block long-term care insurance policies. As of December 31, 2017, it had approximately 14 million members in medical benefit plans, as well as approximately 7 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Receive HUM News and Ratings via Email

Sign-up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:HUM
CUSIP44485910
Phone502-580-1000

Debt

Debt-to-Equity Ratio0.47
Current Ratio1.55
Quick Ratio1.55

Price-To-Earnings

Trailing P/E Ratio25.08
Forward P/E Ratio20.99
P/E Growth1.51

Sales & Book Value

Annual Sales$53.77 billion
Price / Sales0.75
Cash Flow$15.4249 per share
Price / Cash19.04
Book Value$73.22 per share
Price / Book4.01

Profitability

EPS (Most Recent Fiscal Year)$11.71
Net Income$2.45 billion
Net Margins3.36%
Return on Equity16.74%
Return on Assets5.60%

Miscellaneous

Employees45,900
Outstanding Shares137,680,000

Humana (NYSE:HUM) Frequently Asked Questions

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana declared a quarterly dividend on Thursday, April 19th. Investors of record on Friday, June 29th will be paid a dividend of $0.50 per share on Friday, July 27th. This represents a $2.00 dividend on an annualized basis and a yield of 0.68%. The ex-dividend date is Thursday, June 28th. View Humana's Dividend History.

How will Humana's stock buyback program work?

Humana declared that its board has approved a stock repurchase program on Friday, December 15th 2017, which permits the company to repurchase $3,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Shares repurchase programs are typically an indication that the company's leadership believes its stock is undervalued.

How were Humana's earnings last quarter?

Humana (NYSE:HUM) posted its earnings results on Wednesday, May, 2nd. The insurance provider reported $3.36 EPS for the quarter, topping analysts' consensus estimates of $3.21 by $0.15. The insurance provider had revenue of $14.28 billion for the quarter, compared to analyst estimates of $14.22 billion. Humana had a return on equity of 16.74% and a net margin of 3.36%. During the same period in the prior year, the company posted $2.75 earnings per share. View Humana's Earnings History.

When is Humana's next earnings date?

Humana is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for Humana.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY18 earnings guidance on Wednesday, May, 2nd. The company provided earnings per share (EPS) guidance of $13.70-14.10 for the period, compared to the Thomson Reuters consensus estimate of $13.87.

What price target have analysts set for HUM?

17 brokers have issued twelve-month target prices for Humana's stock. Their predictions range from $221.00 to $330.00. On average, they anticipate Humana's stock price to reach $277.2941 in the next year. View Analyst Ratings for Humana.

What are Wall Street analysts saying about Humana stock?

Here are some recent quotes from research analysts about Humana stock:
  • 1. According to Zacks Investment Research, "Shares of Humana have outperformed the industry year to date. The insurer is well-poised for growth on its strong government business. Its top line has been witnessing an uptrend for the past several years. Sufficient generation of cash flow has helped the company take up many capital deployment initiatives aimed at enhancing its shareholders’ value. Humana’s sound balance sheet and a disciplined capital management remain major tailwinds. Following better-than-expected first-quarter results, the company provided a strong guidance for 2018. Also, the company has exited the individual commercial business effective Jan 1, 2018. Rising level of expenses persistently weighs on the bottom line. With respect to quarterly results, Humana’s first-quarter bottom line beat estimates on a favorable current-year medical utilization in Retail segment relative, lower tax rate and a positive impact of share buybacks." (5/21/2018)
  • 2. Cantor Fitzgerald analysts commented, "This morning, Humana announced it would acquire a 40% interest in Curo Health Services, a large, privately-held hospice company." (4/23/2018)

Who are some of Humana's key competitors?

Who are Humana's key executives?

Humana's management team includes the folowing people:
  • Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 56)
  • Mr. Brian Andrew Kane, Sr. VP & CFO (Age 45)
  • Mr. Timothy S. Huval, Chief HR Officer (Age 52)
  • Ms. Jody L. Bilney, Chief Consumer Officer (Age 57)
  • Mr. James Elmer Murray, Advisor (Age 64)

Has Humana been receiving favorable news coverage?

News headlines about HUM stock have trended somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Humana earned a news impact score of 0.21 on Accern's scale. They also gave press coverage about the insurance provider an impact score of 44.30 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

Who are Humana's major shareholders?

Humana's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.85%), Newport Trust Co (1.37%), Wells Fargo & Company MN (1.25%), Northern Trust Corp (1.21%), Dimensional Fund Advisors LP (1.14%) and Legal & General Group Plc (0.54%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.

Which institutional investors are selling Humana stock?

HUM stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, OppenheimerFunds Inc., American Century Companies Inc., Royal Bank of Canada, FIL Ltd, Natixis, State of New Jersey Common Pension Fund D and Wells Fargo & Company MN. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, Elizabeth D Bierbower, Heidi S Margulis, Jody L Bilney, M Todoroff Christopher, Timothy S Huval and William Kevin Fleming. View Insider Buying and Selling for Humana.

Which institutional investors are buying Humana stock?

HUM stock was bought by a variety of institutional investors in the last quarter, including Old Mutual Global Investors UK Ltd., Ceredex Value Advisors LLC, Massachusetts Financial Services Co. MA, BlackRock Inc., Summit Trail Advisors LLC, Mackay Shields LLC, Prudential Financial Inc. and ING Groep NV. View Insider Buying and Selling for Humana.

How do I buy shares of Humana?

Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Humana's stock price today?

One share of HUM stock can currently be purchased for approximately $293.69.

How big of a company is Humana?

Humana has a market capitalization of $40.19 billion and generates $53.77 billion in revenue each year. The insurance provider earns $2.45 billion in net income (profit) each year or $11.71 on an earnings per share basis. Humana employs 45,900 workers across the globe.

How can I contact Humana?

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000.


MarketBeat Community Rating for Humana (HUM)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  604 (Vote Outperform)
Underperform Votes:  688 (Vote Underperform)
Total Votes:  1,292
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe HUM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HUM will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Humana (NYSE:HUM) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
17 Wall Street analysts have issued ratings and price targets for Humana in the last 12 months. Their average twelve-month price target is $277.2941, suggesting that the stock has a possible downside of 5.58%. The high price target for HUM is $330.00 and the low price target for HUM is $221.00. There are currently 5 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.712.722.742.52
Ratings Breakdown: 0 Sell Rating(s)
5 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
10 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $277.2941$274.8889$269.1667$251.80
Price Target Upside: 5.58% downside6.54% downside1.45% upside3.03% upside

Humana (NYSE:HUM) Consensus Price Target History

Price Target History for Humana (NYSE:HUM)

Humana (NYSE:HUM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/3/2018OppenheimerBoost Price TargetOutperform$305.00 ➝ $311.00LowView Rating Details
4/23/2018Cantor FitzgeraldReiterated RatingHold$250.00HighView Rating Details
4/16/2018ArgusBoost Price TargetBuy ➝ Buy$270.00 ➝ $330.00LowView Rating Details
4/4/2018Piper Jaffray CompaniesReiterated RatingBuy$313.00LowView Rating Details
2/12/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$253.00 ➝ $271.00LowView Rating Details
2/9/2018Deutsche BankBoost Price TargetHold ➝ Hold$259.00 ➝ $270.00LowView Rating Details
2/8/2018Leerink SwannBoost Price TargetOutperform ➝ Outperform$280.00 ➝ $300.00HighView Rating Details
2/8/2018Credit Suisse GroupUpgradeNeutral ➝ Outperform$264.90 ➝ $246.00MediumView Rating Details
1/12/2018Jefferies GroupUpgradeHold ➝ Buy$221.00MediumView Rating Details
1/3/2018Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$305.00LowView Rating Details
12/13/2017CowenReiterated RatingBuy$285.00LowView Rating Details
11/10/2017BMO Capital MarketsBoost Price TargetOutperform$290.00 ➝ $300.00N/AView Rating Details
11/9/2017Morgan StanleyLower Price TargetOverweight$276.00 ➝ $270.00N/AView Rating Details
11/9/2017Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$245.00 ➝ $242.00N/AView Rating Details
8/9/2017UBSReiterated RatingNeutral$237.00 ➝ $250.00LowView Rating Details
7/14/2017Bank of AmericaBoost Price TargetBuy$270.00 ➝ $275.00LowView Rating Details
6/28/2017CitigroupInitiated CoverageBuy ➝ Buy$275.00MediumView Rating Details
4/25/2017Evercore ISIReiterated RatingOutperform$240.00LowView Rating Details
3/30/2017CIBCReiterated RatingOutperformLowView Rating Details
1/24/2017Stifel NicolausDowngradeBuy ➝ Hold$214.00 ➝ $210.00N/AView Rating Details
1/9/2017BarclaysReiterated RatingHold$217.00N/AView Rating Details
12/4/2016Susquehanna BancsharesReiterated RatingNeutral$180.00 ➝ $200.00N/AView Rating Details
7/22/2016FBR & CoLower Price TargetMkt Perform$220.00 ➝ $170.00N/AView Rating Details
7/21/2016Wolfe ResearchUpgradeOutperform$192.00N/AView Rating Details
(Data available from 5/25/2016 forward)

Earnings

Humana (NYSE:HUM) Earnings History and Estimates Chart

Earnings by Quarter for Humana (NYSE:HUM)

Humana (NYSE:HUM) Earnings Estimates

2018 EPS Consensus Estimate: $13.79
2019 EPS Consensus Estimate: $16.57
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$3.18$3.21$3.20
Q2 20184$3.70$3.86$3.80
Q3 20184$3.95$4.12$4.02
Q4 20184$2.65$2.97$2.77
Q1 20192$3.72$3.79$3.76
Q2 20192$4.54$4.61$4.58
Q3 20192$4.79$4.93$4.86
Q4 20192$3.34$3.42$3.38

Humana (NYSE HUM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/1/2018$3.88N/AView Earnings Details
5/2/2018Q1 2018$3.21$3.36$14.2230 billion$14.2790 billionViewN/AView Earnings Details
2/7/2018Q4 2017$2.00$2.06$13.1374 billion$13.1890 billionViewListenView Earnings Details
11/8/2017Q3 2017$3.27$3.39$13.4130 billion$13.2820 billionViewN/AView Earnings Details
8/2/2017Q2 2017$3.08$3.49$13.6117 billion$13.5340 billionViewListenView Earnings Details
5/3/2017Q1 2017$2.55$2.75$13.6104 billion$13.7620 billionViewN/AView Earnings Details
2/8/2017Q416$2.05$2.09$13.55 billion$12.88 billionViewN/AView Earnings Details
11/4/2016Q316$3.09$3.18$13.41 billion$13.69 billionViewN/AView Earnings Details
8/3/2016Q216$2.23$2.30$13.59 billion$14.00 billionViewN/AView Earnings Details
5/4/2016Q1$1.81$1.86$13.8024 billion$13.80 billionViewN/AView Earnings Details
2/10/2016Q415$1.45$1.45$13.51 billion$13.40 millionViewN/AView Earnings Details
11/6/2015Q315$2.13$2.16$13.64 billion$13.3630 billionViewN/AView Earnings Details
7/29/2015Q215$1.63$1.67$13.81 billion$13.73 billionViewN/AView Earnings Details
4/29/2015Q115$2.54$2.47$13.51 billion$13.80 billionViewListenView Earnings Details
2/4/2015Q414$1.16$1.09$12.41 billion$12.23 millionViewListenView Earnings Details
11/7/2014Q314$2.01$1.85$12.34 billion$12.2380 billionViewListenView Earnings Details
7/30/2014Q214$2.19$2.19$11.9317 billion$12.2220 billionViewListenView Earnings Details
5/7/2014Q114$1.94$2.35$11.4451 billion$11.7120 billionViewListenView Earnings Details
2/5/2014Q413$0.95($0.19)$10.23 billion$10.20 billionViewListenView Earnings Details
11/6/2013Q313$2.14$2.31$10.27 billion$10.00 billionViewListenView Earnings Details
7/31/2013Q2 2013$2.46$2.63$10.36 billion$10.32 billionViewListenView Earnings Details
5/1/2013Q1 2013$1.80$2.95$10.23 billion$10.49 billionViewListenView Earnings Details
2/4/2013Q4 2012$1.07$1.19$9.73 billion$9.56 billionViewListenView Earnings Details
11/5/2012Q312$2.05$2.62$9.86 billion$9.6510 billionViewN/AView Earnings Details
7/30/2012$2.21$2.16ViewN/AView Earnings Details
4/30/2012$1.54$1.49ViewN/AView Earnings Details
2/6/2012$1.20$1.20ViewN/AView Earnings Details
10/31/2011$2.03$2.54ViewN/AView Earnings Details
8/1/2011$2.05$2.50ViewN/AView Earnings Details
5/2/2011$1.86$1.86ViewN/AView Earnings Details
2/7/2011$0.81$0.63ViewN/AView Earnings Details
11/1/2010Q3 2010$1.67$2.01ViewN/AView Earnings Details
8/2/2010Q2 2010$1.63$2.11ViewN/AView Earnings Details
4/26/2010Q1 2010$1.15$1.20ViewN/AView Earnings Details
2/1/2010Q4 2009$1.48$1.48ViewN/AView Earnings Details
11/2/2009Q3 2009$1.78$1.78ViewN/AView Earnings Details
8/3/2009Q2 2009$1.65$1.67ViewN/AView Earnings Details
4/27/2009Q1 2009$1.14$1.22ViewN/AView Earnings Details
2/2/2009Q4 2008$1.07$1.07ViewN/AView Earnings Details
10/27/2008Q3 2008$1.46$1.48ViewN/AView Earnings Details
8/4/2008Q2 2008$1.18$1.24ViewN/AView Earnings Details
4/28/2008Q1 2008$0.45$0.47ViewN/AView Earnings Details
2/4/2008Q4 2007$1.32$1.43ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Humana (NYSE:HUM) Dividend Information

Humana pays an annual dividend of $2.00 per share, with a dividend yield of 0.68%. HUM's next quarterly dividend payment will be made on Friday, July 27. The company has grown its dividend for the last 7 consecutive years and is increasing its dividend by an average of 10.60% each year. Humana pays out 17.08% of its earnings out as a dividend.
Next Dividend:7/27/2018
Annual Dividend:$2.00
Dividend Yield:0.68%
Dividend Growth:10.60% (3 Year Average)
Payout Ratio(s):17.08% (Trailing 12 Months of Earnings)
14.30% (Based on This Year's Estimates)
11.78% (Based on Next Year's Estimates)
12.97% (Based on Cash Flow)
Track Record:7 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Humana (NYSE:HUM)

Humana (NYSE:HUM) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/19/2018quarterly$0.500.68%6/28/20186/29/20187/27/2018
2/6/2018Quarterly$0.500.74%3/28/20183/30/20184/27/2018
11/2/2017quarterly$0.400.62%12/28/201712/29/20171/26/2018
8/17/2017$0.409/28/20179/29/201710/16/2017
8/17/2017quarterly$0.400.65%9/28/20178/29/201710/27/2017
4/20/2017quarterly$0.400.75%6/28/20176/30/20177/31/2017
2/15/2017quarterly$0.400.78%3/29/20173/31/20174/28/2017
10/26/2016quarterly$0.290.67%1/10/20171/12/20171/27/2017
8/25/2016quarterly$0.290.65%10/11/201610/13/201610/28/2016
4/21/2016quarterly$0.290.66%6/28/20166/30/20167/29/2016
2/18/2016quarterly$0.290.7%3/29/20163/31/20164/29/2016
10/29/2015quarterly$0.290.65%12/28/201512/30/20151/29/2016
8/27/2015quarterly$0.290.63%9/28/20159/30/201510/30/2015
4/17/2015quarterly$0.290.65%6/26/20156/30/20157/31/2015
2/18/2015quarterly$0.280.73%3/27/20153/31/20154/24/2015
10/31/2014quarterly$0.280.81%12/29/201412/31/20141/30/2015
8/27/2014quarterly$0.280.88%9/26/20149/30/201410/31/2014
4/30/2014quarterly$0.281.02%6/26/20146/30/20147/25/2014
2/19/2014quarterly$0.271.06%3/27/20143/31/20144/25/2014
10/30/2013quarterly$0.271.17%12/27/201312/31/20131/31/2014
8/22/2013quarterly$0.271.14%9/26/20139/30/201310/25/2013
4/25/2013quarterly$0.271.47%6/26/20136/28/20137/26/2013
2/27/2013quarterly$0.261.52%3/26/20133/28/20134/26/2013
(Data available from 1/1/2013 forward)

Insider Trades

Humana (NYSE HUM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.60%
Institutional Ownership Percentage: 93.46%
Insider Trading History for Humana (NYSE:HUM)
Institutional Ownership by Quarter for Humana (NYSE:HUM)

Humana (NYSE HUM) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/3/2018Bruce D BroussardCEOSell17,604$286.17$5,037,736.6889,259View SEC Filing  
5/3/2018Heidi S MargulisInsiderSell20,621$285.90$5,895,543.909,220View SEC Filing  
3/9/2018Cynthia H ZipperleSVPSell1,196$273.33$326,902.687,771View SEC Filing  
2/27/2018M Todoroff ChristopherInsiderSell16,389$273.37$4,480,260.9313,447View SEC Filing  
2/26/2018Bruce D BroussardCEOSell14,075$274.32$3,861,054.00113,896View SEC Filing  
12/21/2017Brian P LeclaireSVPSell1,679$245.97$412,983.639,888View SEC Filing  
12/19/2017Timothy S HuvalVPSell1,382$246.04$340,027.2811,557View SEC Filing  
12/18/2017Jody L BilneySVPSell7,054$247.89$1,748,616.0611,704View SEC Filing  
9/1/2017Elizabeth D BierbowerInsiderSell9,786$259.00$2,534,574.0018,042View SEC Filing  
9/1/2017Timothy S HuvalVPSell7,803$258.14$2,014,266.428,831View SEC Filing  
8/23/2017William Kevin FlemingInsiderSell3,071$250.98$770,759.587,681View SEC Filing  
8/11/2017Bruce D BroussardCEOSell12,000$251.88$3,022,560.0080,086View SEC Filing  
8/10/2017M Todoroff ChristopherVPSell22,935$252.52$5,791,546.2024,001View SEC Filing  
6/28/2017Brian P LeclaireSVPSell4,971$240.00$1,193,040.0014,258View SEC Filing  
5/26/2017Heidi S MargulisVPSell1,500$231.96$347,940.008,150View SEC Filing  
5/5/2017Jody L BilneySVPSell4,600$230.16$1,058,736.008,978View SEC Filing  
5/4/2017Bruce D BroussardCEOSell118,231$225.82$26,698,924.42171,170View SEC Filing  
5/4/2017Timothy S HuvalVPSell13,939$225.86$3,148,262.5423,639View SEC Filing  
3/21/2017Jody L BilneySVPSell4,348$213.80$929,602.4013,578View SEC Filing  
3/6/2017James E MurrayCOOSell31,151$213.62$6,654,476.6245,635View SEC Filing  
3/3/2017Cynthia H ZipperleVPSell1,885$213.37$402,202.453,736View SEC Filing  
2/24/2017Brian P LeclaireSVPSell4,971$204.81$1,018,110.5114,258View SEC Filing  
2/22/2017Brian P LeclaireSVPSell26,894$205.24$5,519,724.5625,734View SEC Filing  
2/22/2017James E MurrayCOOSell9,523$204.69$1,949,262.8776,798View SEC Filing  
2/22/2017Roy A BeveridgeVPSell4,832$205.73$994,087.3618,439View SEC Filing  
2/21/2017Bruce D BroussardCEOSell104,256$205.23$21,396,458.88155,108View SEC Filing  
2/21/2017Cynthia H ZipperleCAOSell4,213$204.67$862,274.716,542View SEC Filing  
2/21/2017David A. Jr/Ky JonesDirectorSell27,000$205.04$5,536,080.00View SEC Filing  
2/21/2017James E MurrayCOOSell70,332$205.20$14,432,126.4076,798View SEC Filing  
2/21/2017Jody L BilneySVPSell6,087$204.72$1,246,130.6428,577View SEC Filing  
2/21/2017M Todoroff ChristopherVPSell24,140$205.33$4,956,666.20View SEC Filing  
2/25/2016Brian P LeclaireSVPSell183$176.11$32,228.1317,301View SEC Filing  
3/11/2015James E MurrayCOOSell35,220$160.90$5,666,898.00View SEC Filing  
3/2/2015Brian P LeclaireSVPSell5,500$161.79$889,845.00View SEC Filing  
2/25/2015Bruce D BroussardCEOSell41,105$165.29$6,794,245.45View SEC Filing  
2/25/2015David A Jr/Ky JonesDirectorSell6,100$165.39$1,008,879.00View SEC Filing  
2/24/2015Heidi S MargulisVPSell3,665$164.44$602,672.60View SEC Filing  
8/22/2014Brian P LeclaireSVPSell3,250$123.04$399,880.00View SEC Filing  
5/15/2014Heidi MargulisVPSell3,345$119.56$399,928.208,730View SEC Filing  
5/12/2014Marissa PetersonDirectorSell2,026$123.30$249,805.801,358View SEC Filing  
3/19/2014James MurrayCOOSell36,833$116.59$4,294,359.4789,892View SEC Filing  
3/18/2014M Todoroff ChristopherVPSell8,000$113.20$905,600.0018,225View SEC Filing  
3/13/2014Bruce BroussardCEOSell109,000$109.84$11,972,560.0059,944View SEC Filing  
3/10/2014Webster Roy DunbarDirectorSell9,587$110.30$1,057,446.101,458View SEC Filing  
12/4/2013Marissa PetersonDirectorSell1,147$103.54$118,760.38View SEC Filing  
12/2/2013M Todoroff ChristopherVPSell6,000$105.50$633,000.0016,226View SEC Filing  
11/26/2013Heidi MargulisVPSell5,500$104.42$574,310.007,136View SEC Filing  
11/8/2013David Jr/Ky JonesDirectorSell11,000$95.00$1,045,000.00143,339View SEC Filing  
9/5/2013Elizabeth D BierbowerInsiderSell17,673$96.01$1,696,784.73View SEC Filing  
8/30/2013Heidi MargulisVPSell3,319$93.35$309,828.6510,801View SEC Filing  
8/29/2013David Jr/Ky JonesDirectorSell2,500$93.01$232,525.00154,339View SEC Filing  
8/23/2013Elizabeth BierbowerInsiderSell6,063$94.00$569,922.0016,473View SEC Filing  
8/15/2013Michael MccallisterDirectorSell138,817$91.49$12,700,367.33111,859View SEC Filing  
8/13/2013Bruce PerkinsInsiderSell9,000$93.47$841,230.0010,985View SEC Filing  
8/8/2013Steven McculleyVPSell10,000$92.54$925,400.009,327View SEC Filing  
8/7/2013James BloemCFOSell33,000$91.79$3,029,070.0021,767View SEC Filing  
8/1/2013M Todoroff ChristopherVPSell39,596$90.30$3,575,518.80View SEC Filing  
6/24/2013Paul B K KusserowSVPSell34,219$84.60$2,894,927.40View SEC Filing  
6/18/2013Elizabeth D BierbowerInsiderSell8,033$83.29$669,068.57View SEC Filing  
5/30/2013James E MurrayCOOSell11,000$81.96$901,560.00View SEC Filing  
5/9/2013Michael B MccallisterDirectorSell281,312$77.72$21,863,568.64View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Humana (NYSE HUM) News Headlines

Source:
DateHeadline
Humana Teams up with Jefferson Regional Medical Center and Arkansas Department of Health to Promote ...Humana Teams up with Jefferson Regional Medical Center and Arkansas Department of Health to Promote ...
www.businesswire.com - May 23 at 4:35 PM
Broussard on why Humana invested in primary care startupBroussard on why Humana invested in primary care startup
www.bizjournals.com - May 23 at 4:35 PM
FY2018 EPS Estimates for Humana (HUM) Lifted by AnalystFY2018 EPS Estimates for Humana (HUM) Lifted by Analyst
www.americanbankingnews.com - May 23 at 7:24 AM
Humana adding jobs in TampaHumana adding jobs in Tampa
www.bizjournals.com - May 22 at 4:34 PM
Humana AB’s (STO:HUM) Earnings Dropped -11.95%, How Did It Fare Against The Industry?Humana AB’s (STO:HUM) Earnings Dropped -11.95%, How Did It Fare Against The Industry?
finance.yahoo.com - May 22 at 9:07 AM
Zacks Industry Outlook Highlights: UnitedHealth, Anthem, Aetna, Cigna and HumanaZacks Industry Outlook Highlights: UnitedHealth, Anthem, Aetna, Cigna and Humana
finance.yahoo.com - May 21 at 9:26 AM
Form 4 HUMANA INC For: May 18 Filed by: BEVERIDGE, ROY AForm 4 HUMANA INC For: May 18 Filed by: BEVERIDGE, ROY A
www.streetinsider.com - May 19 at 9:21 AM
Zacks Investment Research Lowers Humana (HUM) to HoldZacks Investment Research Lowers Humana (HUM) to Hold
www.americanbankingnews.com - May 18 at 4:51 PM
Customer Satisfaction ETF Tops $50 Million in AssetsCustomer Satisfaction ETF Tops $50 Million in Assets
finance.yahoo.com - May 18 at 4:36 PM
Humana Inc. 2018 Q1 - Results - Earnings Call SlidesHumana Inc. 2018 Q1 - Results - Earnings Call Slides
seekingalpha.com - May 16 at 4:38 PM
Humana hiring 80 phone sales positionsHumana hiring 80 phone sales positions
finance.yahoo.com - May 16 at 4:38 PM
Humana seeks to fill 90 jobs in South FloridaHumana seeks to fill 90 jobs in South Florida
www.bizjournals.com - May 15 at 4:34 PM
5 Reasons Why You Must Add Humana (HUM) to Your Portfolio5 Reasons Why You Must Add Humana (HUM) to Your Portfolio
www.zacks.com - May 15 at 4:34 PM
Humana To Present At BOA Merrill Lynch Conference; Webcast At 8:00 PM ETHumana To Present At BOA Merrill Lynch Conference; Webcast At 8:00 PM ET
www.nasdaq.com - May 15 at 4:34 PM
 Brokerages Expect Humana (HUM) Will Post Quarterly Sales of $14.16 Billion Brokerages Expect Humana (HUM) Will Post Quarterly Sales of $14.16 Billion
www.americanbankingnews.com - May 15 at 4:04 AM
Is There An Opportunity With Humana AB’s (STO:HUM) 27% Undervaluation?Is There An Opportunity With Humana AB’s (STO:HUM) 27% Undervaluation?
finance.yahoo.com - May 13 at 9:47 AM
Zacks: Brokerages Expect Humana (HUM) to Post $3.80 EPSZacks: Brokerages Expect Humana (HUM) to Post $3.80 EPS
www.americanbankingnews.com - May 13 at 8:56 AM
How Humana And Walmart Can Overcome Organizational Autoimmune DiseaseHow Humana And Walmart Can Overcome Organizational Autoimmune Disease
www.forbes.com - May 11 at 10:27 AM
HC2 Holdings Reports First Quarter 2018 ResultsHC2 Holdings Reports First Quarter 2018 Results
finance.yahoo.com - May 10 at 4:34 PM
Piper Jaffray Comments on Humanas Q2 2019 Earnings (HUM)Piper Jaffray Comments on Humana's Q2 2019 Earnings (HUM)
www.americanbankingnews.com - May 10 at 8:47 AM
Humana (HUM) Receives Average Recommendation of "Buy" from BrokeragesHumana (HUM) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - May 10 at 5:37 AM
Humana Inc. to Present at the Bank of America Merrill Lynch Health Care ConferenceHumana Inc. to Present at the Bank of America Merrill Lynch Health Care Conference
finance.yahoo.com - May 9 at 4:34 PM
Humana to Post Q2 2018 Earnings of $3.86 Per Share, Piper Jaffray Forecasts (HUM)Humana to Post Q2 2018 Earnings of $3.86 Per Share, Piper Jaffray Forecasts (HUM)
www.americanbankingnews.com - May 9 at 8:45 AM
Humana To Present At Deutsche Bank Conference; Webcast At 11:20 AM ETHumana To Present At Deutsche Bank Conference; Webcast At 11:20 AM ET
www.nasdaq.com - May 8 at 4:34 PM
to Address Food Insecurity Among Veterans Across the Countryto Address Food Insecurity Among Veterans Across the Country
www.businesswire.com - May 8 at 4:34 PM
Humana Partners with Feeding America® to Address Food Insecurity Among Veterans Across the CountryHumana Partners with Feeding America® to Address Food Insecurity Among Veterans Across the Country
finance.yahoo.com - May 8 at 4:34 PM
Form 4 HUMANA INC For: May 03 Filed by: BROUSSARD BRUCE DForm 4 HUMANA INC For: May 03 Filed by: BROUSSARD BRUCE D
www.streetinsider.com - May 7 at 4:37 PM
Form 4 HUMANA INC For: May 03 Filed by: MARGULIS HEIDI SForm 4 HUMANA INC For: May 03 Filed by: MARGULIS HEIDI S
www.streetinsider.com - May 7 at 4:37 PM
Humana plans to add up to 50 new national jobs in San AntonioHumana plans to add up to 50 new national jobs in San Antonio
www.bizjournals.com - May 7 at 4:37 PM
Heres how much Humana is spending on its state-of-the-art gymHere's how much Humana is spending on its state-of-the-art gym
www.bizjournals.com - May 7 at 4:37 PM
Insider Selling: Humana (HUM) Insider Sells 20,621 Shares of StockInsider Selling: Humana (HUM) Insider Sells 20,621 Shares of Stock
www.americanbankingnews.com - May 7 at 4:34 PM
Bruce D. Broussard Sells 17,604 Shares of Humana (HUM) StockBruce D. Broussard Sells 17,604 Shares of Humana (HUM) Stock
www.americanbankingnews.com - May 7 at 4:34 PM
Humana (HUM) PT Raised to $291 at JPMorganHumana (HUM) PT Raised to $291 at JPMorgan
www.streetinsider.com - May 7 at 9:57 AM
Q2 2018 EPS Estimates for Humana Reduced by Leerink Swann (HUM)Q2 2018 EPS Estimates for Humana Reduced by Leerink Swann (HUM)
www.americanbankingnews.com - May 7 at 2:08 AM
Oppenheimer Research Analysts Lower Earnings Estimates for Humana (HUM)Oppenheimer Research Analysts Lower Earnings Estimates for Humana (HUM)
www.americanbankingnews.com - May 7 at 2:08 AM
Humana CEO, other executive offload millions of dollars in stockHumana CEO, other executive offload millions of dollars in stock
www.bizjournals.com - May 4 at 4:37 PM
2018 Healthiest Employers winner: Humana2018 Healthiest Employers winner: Humana
www.bizjournals.com - May 4 at 9:16 AM
Humana Inc. to Present at the Deutsche Bank 43rd Annual Health Care ConferenceHumana Inc. to Present at the Deutsche Bank 43rd Annual Health Care Conference
finance.yahoo.com - May 4 at 9:16 AM
Make sure this key ingredient is part of your retirementMake sure this key ingredient is part of your retirement
finance.yahoo.com - May 4 at 9:16 AM
Humana Expected to Earn Q3 2018 Earnings of $4.05 Per Share (HUM)Humana Expected to Earn Q3 2018 Earnings of $4.05 Per Share (HUM)
www.americanbankingnews.com - May 4 at 7:42 AM
Humana (HUM) Expected to Post Q2 2018 Earnings of $3.70 Per ShareHumana (HUM) Expected to Post Q2 2018 Earnings of $3.70 Per Share
www.americanbankingnews.com - May 4 at 6:46 AM
Oppenheimer Boosts Humana (HUM) Price Target to $311.00Oppenheimer Boosts Humana (HUM) Price Target to $311.00
www.americanbankingnews.com - May 3 at 8:34 PM
Humana (HUM) PT Raised to $311 at OppenheimerHumana (HUM) PT Raised to $311 at Oppenheimer
www.streetinsider.com - May 3 at 4:31 PM
Why Humana was named one of the most diverse companies in the USWhy Humana was named one of the most diverse companies in the US
www.bizjournals.com - May 3 at 4:31 PM
Edited Transcript of HUM earnings conference call or presentation 2-May-18 1:00pm GMTEdited Transcript of HUM earnings conference call or presentation 2-May-18 1:00pm GMT
finance.yahoo.com - May 3 at 4:31 PM
Humana already developing strategy for Kindred At HomeHumana already developing strategy for Kindred At Home
finance.yahoo.com - May 3 at 4:31 PM
How Healthcare Disruption Will Help RetailersHow Healthcare Disruption Will Help Retailers
finance.yahoo.com - May 3 at 4:31 PM
AM Best Affirms Credit Ratings of Humana Inc. and Its SubsidiariesAM Best Affirms Credit Ratings of Humana Inc. and Its Subsidiaries
www.businesswire.com - May 3 at 9:16 AM
How Humana Already Benefits From Walmart Retail Store TrafficHow Humana Already Benefits From Walmart Retail Store Traffic
finance.yahoo.com - May 3 at 9:16 AM
A.M. Best Affirms Credit Ratings of Humana Inc. and Its SubsidiariesA.M. Best Affirms Credit Ratings of Humana Inc. and Its Subsidiaries
finance.yahoo.com - May 3 at 9:16 AM

SEC Filings

Humana (NYSE:HUM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Humana (NYSE:HUM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Humana (NYSE HUM) Stock Chart for Friday, May, 25, 2018

Loading chart…

This page was last updated on 5/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.